Dr. Deborah A. Scott, MD
Dermatology (Dermatology Physician)
850 Boylston St, Brigham And Womens Hospital Ste 402
Chestnut Hill, MA 02467
- Medicare participating
At a glance
- Medical school
- Howard University College of Medicine (1979)
- Years since graduation
- 47
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 327
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1979Medical school: Howard University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
MA license 71981
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
Medical groups
- Brigham and Womens Physicians Organization Inc (2,994 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 327
- Services billed
- 915
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 238 | 63 |
| Established patient office or other outpatient visit, 30-39 minutes | 220 | 180 |
| Established patient office or other outpatient visit, 20-29 minutes | 186 | 165 |
| Destruction of precancer skin growth, 1 growth | 93 | 87 |
| Biopsy of related skin growth, first growth | 54 | 49 |
| Application of light with debridement to destroy precancer skin growth | 32 | 22 |
| Biopsy of related skin growth, each additional growth | 26 | 15 |
| Destruction of skin growth, 1-14 growths | 25 | 24 |
| New patient office or other outpatient visit, 45-59 minutes | 22 | 22 |
| Punch biopsy, first skin growth | 18 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $20.87 in total to this clinician.
| Revance Therapeutics, Inc. | $20.87 |
|---|
| Food and Beverage | $20.87 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.